Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann–Pick disease type C treatmentYusei Yamada(University of Miyazaki Hospital), Yoichi Ishitsuka(Unknown)Clinical and Translational MedicineAugust 1, 202310.1002/ctm2.1350Cited by 16SaveCiteExport RISWatch citationsRelated PapersA system that delivers an antioxidant to mitochondria for the treatment of drug-induced liver injury|Scientific Reports|2023|24The Late-Stage Protective Effect of Mito-TEMPO against Acetaminophen-Induced Hepatotoxicity in Mouse and Three-Dimensional Cell Culture Models|Antioxidants|2020|21